<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04624854</url>
  </required_header>
  <id_info>
    <org_study_id>DAPT-MVD-201912</org_study_id>
    <nct_id>NCT04624854</nct_id>
  </id_info>
  <brief_title>Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)</brief_title>
  <official_title>Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD): A Prospective, Multicenter, Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harbin Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chinese Society of Cardiology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lepu Medical Technology (Beijing) Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Harbin Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, multicenter, parallel, open-label, randomized, controlled,&#xD;
      superiority trial. It is planned to recruit 8,250 patients with multi-vessel disease(MVD),&#xD;
      and the patients will be followed-up for 12 months after being implanted with a drug-eluting&#xD;
      stent (DES) at one of 100 different centers. All patients will be randomly divided into the&#xD;
      treatment group and control group on a 1:1 basis, based on a complete randomization.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 27, 2020</start_date>
  <completion_date type="Anticipated">October 26, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 26, 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>All patients will be randomly divided into the treatment group and control group on a 1:1 basis, based on a complete randomization. The treatment group will use aspirin + clopidogrel dual anti-platelet therapy for 12 months, and the control group will use aspirin monotherapy for 12 months.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>This is an open-label trial, and the investigators and subjects will not be blinded. Under these conditions, the following methods will be employed to minimize bias:&#xD;
Clinical Endpoint Committee (CEC) is an independent group of experts that reviews clinical trial data in order to give expert opinions about clinical safety or efficacy events of interest;&#xD;
The statisticians are independent and blind to the grouping information.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of MACCE(cardiovascular death, nonfatal myocardial infarction or nonfatal stroke).</measure>
    <time_frame>12 months after randomization.</time_frame>
    <description>To evaluate the effect of Clopidogrel and Aspirin dual-antiplatelet therapy on the incidence of MACCE in patients with MVD</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of all-cause mortality.</measure>
    <time_frame>12 months after randomization.</time_frame>
    <description>To evaluate the effect of Clopidogrel and Aspirin dual-antiplatelet therapy on the incidence of all-cause mortality in patients with MVD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of cardiovascular death.</measure>
    <time_frame>12 months after randomization.</time_frame>
    <description>To evaluate the effect of Clopidogrel and Aspirin dual-antiplatelet therapy on the incidence of cardiovascular death in patients with MVD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of nonfatal myocardial infarction.</measure>
    <time_frame>12 months after randomization.</time_frame>
    <description>To evaluate the effect of Clopidogrel and Aspirin dual-antiplatelet therapy on the incidence of nonfatal myocardial infarction in patients with MVD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of nonfatal stroke.</measure>
    <time_frame>12 months after randomization.</time_frame>
    <description>To evaluate the effect of Clopidogrel and Aspirin dual-antiplatelet therapy on the incidence of nonfatal stroke in patients with MVD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of clinical adverse events.</measure>
    <time_frame>12 months after randomization.</time_frame>
    <description>To evaluate the effect of Clopidogrel and Aspirin dual-antiplatelet therapy on the incidence of clinical adverse events (MACCE and BARC defined as type 2-5) in patients with MVD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of cardiovascular death or hospitalization.</measure>
    <time_frame>12 months after randomization.</time_frame>
    <description>To evaluate the effect of Clopidogrel and Aspirin dual-antiplatelet therapy on the incidence of cardiovascular death or hospitalization (myocardial infarction, stroke, emergency revascularization, unstable angina or TIA) caused by thrombotic events in patients with MVD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of emergency revascularization.</measure>
    <time_frame>12 months after randomization.</time_frame>
    <description>To evaluate the effect of Clopidogrel and Aspirin dual-antiplatelet therapy on the incidence of emergency revascularization in patients with MVD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of repeat revascularization.</measure>
    <time_frame>12 months after randomization.</time_frame>
    <description>To evaluate the effect of Clopidogrel and Aspirin dual-antiplatelet therapy on the incidence of any repeat revascularization in patients with MVD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of definite/possible stent thrombosis.</measure>
    <time_frame>12 months after randomization.</time_frame>
    <description>To evaluate the effect of Clopidogrel and Aspirin dual-antiplatelet therapy on the incidence of definite/possible stent thrombosis in patients with MVD.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of clinically relevant bleeding events.</measure>
    <time_frame>12 months after randomization.</time_frame>
    <description>To evaluate the effect of Clopidogrel and Aspirin dual-antiplatelet therapy on the incidence of clinically relevant bleeding events (BARC, defined as type 2-5) in patients with MVD.</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of major bleeding events.</measure>
    <time_frame>12 months after randomization.</time_frame>
    <description>To evaluate the effect of Clopidogrel and Aspirin dual-antiplatelet therapy on the incidence of major bleeding events (BARC, defined as type3-5) in patients with MVD.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">8250</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Myocardial Ischemia</condition>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Heart Diseases</condition>
  <condition>Syndrome Heart Disease</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Arteriosclerosis</condition>
  <condition>Arterial Occlusive Diseases</condition>
  <condition>Coronary Disease</condition>
  <condition>Vascular Diseases</condition>
  <arm_group>
    <arm_group_label>Aspirin monotherapy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive aspirin monotherapy without co-administration of clopidogrel for 12 months after randomization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clopidogrel and Aspirin dual-antiplatelet therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive co-administration of clopidogrel and aspirin for 12 months after randomization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clopidogrel and Aspirin dual-antiplatelet therapy</intervention_name>
    <description>Patients will receive co-administration of clopidogrel and aspirin for 12 months after randomization.</description>
    <arm_group_label>Clopidogrel and Aspirin dual-antiplatelet therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin monotherapy</intervention_name>
    <description>Patients will receive aspirin monotherapy without co-administration of clopidogrel for 12 months after randomization.</description>
    <arm_group_label>Aspirin monotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The enrolled subjects must meet all of the following criteria:&#xD;
&#xD;
               1. Aged 18-75 years old (inclusive).&#xD;
&#xD;
               2. Patients with MVD who underwent DES implantation for 12 months.&#xD;
&#xD;
               3. Patients have been treated with aspirin and can tolerant of aspirin at doses of&#xD;
                  75-150 mg/day as maintenance therapy during the study period.&#xD;
&#xD;
               4. Patients have signed informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Subjects who meet any one of the following criteria are excluded from the study:&#xD;
&#xD;
          1. Planned to use of ADP receptor blockers (eg, clopidogrel, ticagrelor, and&#xD;
             ticlopidine), dipyridamole, or cilostazol.&#xD;
&#xD;
          2. Contraindication to ADP receptor blockers or aspirin.&#xD;
&#xD;
          3. Planned to use anticoagulants during the study period.&#xD;
&#xD;
          4. Planned coronary, cerebrovascular, or peripheral arterial revascularization during the&#xD;
             study period.&#xD;
&#xD;
          5. Planned major cardiac or non-cardiac surgery during the study period.&#xD;
&#xD;
          6. Concomitant oral or intravenous therapy with CYP2C19 medium or strong inhibitors.&#xD;
&#xD;
          7. Known severe liver disease(ALT/AST is 3 times above normal).&#xD;
&#xD;
          8. Subjects with renal failure who required or anticipated dialysis during the study&#xD;
             period.&#xD;
&#xD;
          9. Platelet count &lt;50×10^9/L.&#xD;
&#xD;
         10. Patients with:&#xD;
&#xD;
               -  A history of intracranial bleed or ischemic stroke at any time.&#xD;
&#xD;
               -  A central nervous system tumor or intracranial vascular abnormality (eg,&#xD;
                  aneurysm, arteriovenous malformation) at any time.&#xD;
&#xD;
               -  Intracranial or spinal cord surgery within 5 years.&#xD;
&#xD;
         11. Pregnancy or lactation or planned to pregnant during the study period.&#xD;
&#xD;
         12. Life expectancy &lt; 1 year.&#xD;
&#xD;
         13. Any condition which in the opinion of the investigator would make it unsafe or&#xD;
             unsuitable for the patient to participate in this study (eg, active malignancy other&#xD;
             than squamous cell or basal cell skin cancer).&#xD;
&#xD;
         14. Concern for inability of the patient to comply with study procedures and/or followup&#xD;
             (eg, alcohol or drug abuse).&#xD;
&#xD;
         15. Participation in another clinical study and did not reach the major endpoint.&#xD;
&#xD;
         16. Involvement in the planning and/or conduct of the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bo Yu, M.D.,FACC</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Second Affiliated Hospital of Harbin Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jinwei Tian, M.D.,FACC</last_name>
    <phone>+86 18545851107</phone>
    <email>tianjinweidr2009@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tangshan Central Hospital</name>
      <address>
        <city>Tangshan</city>
        <state>Hebei</state>
        <zip>063099</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Affiliated Beijing Luhe Hospital of Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>101149</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400042</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiangsen Shao</last_name>
      <phone>+8617316751907</phone>
      <email>896862671@qq.com</email>
    </contact>
    <investigator>
      <last_name>Chunchang Qin, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fujian Provincial Hospital</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaiyang Lin</last_name>
      <phone>+8615622336793</phone>
      <email>75345844@qq.com</email>
    </contact>
    <investigator>
      <last_name>Yansong Guo, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xiamen Fifth Hospital</name>
      <address>
        <city>Xiamen</city>
        <state>Fujian</state>
        <zip>361101</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yandong Fu, MD,PhD</last_name>
      <phone>+8619559247953</phone>
      <email>fyd00001@126.com</email>
    </contact>
    <investigator>
      <last_name>Yandong Fu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pingquan County Hospital</name>
      <address>
        <city>Qingyang</city>
        <state>Gansu</state>
        <zip>744517</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yulian Zhang</last_name>
      <phone>+8617725599881</phone>
      <email>pqxyyxnk@163.com</email>
    </contact>
    <investigator>
      <last_name>Jingchao Huang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shenzhen People's Hospital</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>518000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Guangdong Provincial People's Hospital</name>
      <address>
        <city>Zhongshan</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yibo He</last_name>
      <phone>+8615603072684</phone>
      <email>heyibo2011@163.com</email>
    </contact>
    <investigator>
      <last_name>Yong Liu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hezhou People's Hospital</name>
      <address>
        <city>Hezuo</city>
        <state>Guangxi</state>
        <zip>542800</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Zunyi Medical University</name>
      <address>
        <city>Zunyi</city>
        <state>Guizhou</state>
        <zip>563003</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Haikou People's Hospital</name>
      <address>
        <city>Haikou</city>
        <state>Hainan</state>
        <zip>570208</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hainan General Hospital</name>
      <address>
        <city>Haikou</city>
        <state>Hainan</state>
        <zip>570311</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wang Liao</last_name>
      <phone>+8613518827831</phone>
      <email>crain_lw@163.com</email>
    </contact>
    <investigator>
      <last_name>Wang Liao, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cangzhou Central Hospital</name>
      <address>
        <city>Cangzhou</city>
        <state>Hebei</state>
        <zip>061014</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guangren Gao</last_name>
      <phone>+8618031792908</phone>
      <email>gaoguangren2004@163.com</email>
    </contact>
    <investigator>
      <last_name>Jun Zhang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Chengde Medical University</name>
      <address>
        <city>Chengde</city>
        <state>Hebei</state>
        <zip>067000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weichao Shan</last_name>
      <phone>+8618503147606</phone>
      <email>16442297@qq.com</email>
    </contact>
    <investigator>
      <last_name>Zhenjiang Ding, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harrison International Peace Hospital</name>
      <address>
        <city>Hengshui</city>
        <state>Hebei</state>
        <zip>053000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiandong Xiao</last_name>
      <phone>+8615031828120</phone>
      <email>xiaojiandong5188@163.com</email>
    </contact>
    <investigator>
      <last_name>Qun Zheng, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third Hospital of Shijiazhuang</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>052360</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Xingtai Third Hospital</name>
      <address>
        <city>Xingtai</city>
        <state>Hebei</state>
        <zip>054000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Daqing Long Nan Hospital</name>
      <address>
        <city>Daqing</city>
        <state>Heilongjiang</state>
        <zip>163001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lei Cai, MD,PhD</last_name>
      <phone>+8613504653780</phone>
      <email>780mm@163.com</email>
    </contact>
    <investigator>
      <last_name>Lei Cai, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Daqing Oilfield General Hospital</name>
      <address>
        <city>Daqing</city>
        <state>Heilongjiang</state>
        <zip>163316</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Daqing People's Hosipital</name>
      <address>
        <city>Daqing</city>
        <state>Heilongjiang</state>
        <zip>163316</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoyan Liu</last_name>
      <phone>+8613845936110</phone>
      <email>lxy215@163.com</email>
    </contact>
    <investigator>
      <last_name>Shu Zhang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Daxing'anling Prefecture People's Hospital</name>
      <address>
        <city>Daxing'anling</city>
        <state>Heilongjiang</state>
        <zip>165000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Du</last_name>
      <phone>+8613904570425</phone>
      <email>271938499@qq.com</email>
    </contact>
    <investigator>
      <last_name>Dalei Qi, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Fourth Affiliated Hospital of Harbin Medical University</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yang Yu</last_name>
      <phone>+8615846568703</phone>
      <email>zhijixin23@163.com</email>
    </contact>
    <investigator>
      <last_name>Jixin Zhi, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harbin First Hospital</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150010</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rui Cao</last_name>
      <phone>+8615776744113</phone>
      <email>363557222@qq.com</email>
    </contact>
    <investigator>
      <last_name>Wanbin Zheng, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jian Li, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heilongjiang Province Hospital</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xuefeng Tian</last_name>
      <phone>+8613009994672</phone>
      <email>tianxuefengsyy@163.com</email>
    </contact>
    <investigator>
      <last_name>Zheng Wang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harbin Second Hospital</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150056</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hui Li</last_name>
      <phone>+8613199489905</phone>
      <email>lele20080701@126.com</email>
    </contact>
    <investigator>
      <last_name>Guohua Zhang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harbin 242 Hospital</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150066</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiubin Sun</last_name>
      <phone>+8613796016890</phone>
      <email>joe6890@163.com</email>
    </contact>
    <investigator>
      <last_name>Yin Zhou, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The 2nd Affiliated Hospital of Harbin Medical University</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150086</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jinwei Tian, MD,PhD</last_name>
      <phone>+8645186605180</phone>
      <email>Tianjinweidr2009@163.com</email>
    </contact>
    <investigator>
      <last_name>Bo Yu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Cancer Hospital of Heilongjiang Province</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150088</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kexin Zhao</last_name>
      <phone>+8615754519938</phone>
      <email>caopeigang@126.com</email>
    </contact>
    <investigator>
      <last_name>Peigang Cao, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shuangcheng People's Hospital</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150100</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaofeng Mei</last_name>
      <phone>+8613836199982</phone>
      <email>382648103@qq.com</email>
    </contact>
    <investigator>
      <last_name>Aiguo Sun, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hegang Mining Group General Hospital</name>
      <address>
        <city>Hegang</city>
        <state>Heilongjiang</state>
        <zip>154100</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiufu Li</last_name>
      <phone>+8615545808255</phone>
      <email>777353322@qq.com</email>
    </contact>
    <investigator>
      <last_name>Xiangli Shen, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hegang People's Hospital</name>
      <address>
        <city>Hegang</city>
        <state>Heilongjiang</state>
        <zip>154100</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jing Yao</last_name>
      <phone>+8618704686686</phone>
      <email>103025271@qq.com</email>
    </contact>
    <investigator>
      <last_name>Xiangming Wang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heilongjiang Provincial Agricultural Reclamation Baoquanling Administration Center Hospital</name>
      <address>
        <city>Hegang</city>
        <state>Heilongjiang</state>
        <zip>154211</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jing liu</last_name>
      <phone>+8613895922521</phone>
      <email>147416596@qq.com</email>
    </contact>
    <investigator>
      <last_name>Jun Jiang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nenjiang People's Hospital</name>
      <address>
        <city>Heihe</city>
        <state>Heilongjiang</state>
        <zip>161400</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Central Hospital of Jiamusi City</name>
      <address>
        <city>Jiamusi</city>
        <state>Heilongjiang</state>
        <zip>150086</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qi Zhang</last_name>
      <phone>+8618249251087</phone>
      <email>zhangqi19840819@aliyun.com</email>
    </contact>
    <investigator>
      <last_name>Zhiyuan Weng, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Li Zhang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lianfeng Yang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shi Yin, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Jamusi University</name>
      <address>
        <city>Jiamusi</city>
        <state>Heilongjiang</state>
        <zip>154002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ze Sun</last_name>
      <phone>+8615694549908</phone>
      <email>gaoshan1963@sina.com</email>
    </contact>
    <investigator>
      <last_name>Shan Gao, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Jiansanjiang People's Hospital of Heilongjiang Land Reclamation</name>
      <address>
        <city>Jiamusi</city>
        <state>Heilongjiang</state>
        <zip>156300</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiaxin Shi</last_name>
      <phone>+8613694549641</phone>
      <email>414816268@qq.com</email>
    </contact>
    <investigator>
      <last_name>Shujiang Zhang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jixi Jikuang Hospital</name>
      <address>
        <city>Jixi</city>
        <state>Heilongjiang</state>
        <zip>158100</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhenguo Xu</last_name>
      <phone>+8613936266257</phone>
      <email>357825046@qq.com</email>
    </contact>
    <investigator>
      <last_name>Dongmu Chai, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jixi People's Hospital</name>
      <address>
        <city>Jixi</city>
        <state>Heilongjiang</state>
        <zip>158100</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bin Wang</last_name>
      <phone>+8615146762150</phone>
      <email>bearsoon@126.com</email>
    </contact>
    <investigator>
      <last_name>Xibin Tan, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mishan People's Hospital</name>
      <address>
        <city>Mishan</city>
        <state>Heilongjiang</state>
        <zip>158300</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zijun Guo</last_name>
      <phone>+8613936266257</phone>
      <email>hsm6766@126.com</email>
    </contact>
    <investigator>
      <last_name>Shangmin Hu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mudanjiang City Second People's Hospital</name>
      <address>
        <city>Mudanjiang</city>
        <state>Heilongjiang</state>
        <zip>157000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jinlong He</last_name>
      <phone>+86113766664610</phone>
      <email>68818591@qq.com</email>
    </contact>
    <investigator>
      <last_name>Xiaodong Ji, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hongqi Hospital of Mudanjiang Medical University</name>
      <address>
        <city>Mudanjiang</city>
        <state>Heilongjiang</state>
        <zip>157011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiaoxia Yang</last_name>
      <phone>+8613766590079</phone>
      <email>jiaoxiayang1977@163.com</email>
    </contact>
    <investigator>
      <last_name>Fengmin Gao, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mudanjiang Cardiovascular Hospital</name>
      <address>
        <city>Mudanjiang</city>
        <state>Heilongjiang</state>
        <zip>157011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shan Zhang</last_name>
      <phone>+8618704537080</phone>
      <email>40230303@qq.com</email>
    </contact>
    <investigator>
      <last_name>Kai Liu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lianmin Wang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mudanjiang First People's Hospital</name>
      <address>
        <city>Mudanjiang</city>
        <state>Heilongjiang</state>
        <zip>157011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mingxia Han</last_name>
      <phone>+8613845358606</phone>
      <email>hanmingxia2005@163.com</email>
    </contact>
    <investigator>
      <last_name>Mingxia Han, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mudanjiang Administration Center Hospital of Heilongjiang Land Reclamation</name>
      <address>
        <city>Mudanjiang</city>
        <state>Heilongjiang</state>
        <zip>158322</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhongfei Yu</last_name>
      <phone>+8613836586642</phone>
      <email>752277354@qq.com</email>
    </contact>
    <investigator>
      <last_name>Shufang Yin, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Qiqihar Jianhua Hospital</name>
      <address>
        <city>Qiqihar</city>
        <state>Heilongjiang</state>
        <zip>161000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongbo Tang</last_name>
      <phone>+8613936266257</phone>
      <email>113157362@163.com</email>
    </contact>
    <investigator>
      <last_name>Bo Jiang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third Affiliated Hospital of Qiqihar Medical University</name>
      <address>
        <city>Qiqihar</city>
        <state>Heilongjiang</state>
        <zip>161000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chunyu Jiang</last_name>
      <phone>+8613904523434</phone>
      <email>xiaoyu7606@163.com</email>
    </contact>
    <investigator>
      <last_name>Yanxiang Shen, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Qiqihar Medical University</name>
      <address>
        <city>Qiqihar</city>
        <state>Heilongjiang</state>
        <zip>161006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jia Liu</last_name>
      <phone>+8613514644939</phone>
      <email>bingyuci2@126.com</email>
    </contact>
    <investigator>
      <last_name>Guiqing Liu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emergency General Hospital of Shuangyashan</name>
      <address>
        <city>Shuangyashan</city>
        <state>Heilongjiang</state>
        <zip>155100</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jie Zhao</last_name>
      <phone>+8613555168891</phone>
      <email>hlc67108@163.com</email>
    </contact>
    <investigator>
      <last_name>Hui Li, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shuangyashan People's Hospital</name>
      <address>
        <city>Shuangyashan</city>
        <state>Heilongjiang</state>
        <zip>155100</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenjia Zhou</last_name>
      <phone>+8613936266257</phone>
      <email>zhouwenjia198306@163.com</email>
    </contact>
    <investigator>
      <last_name>Feng Yu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The People's Hospital of Baoqing</name>
      <address>
        <city>Shuangyashan</city>
        <state>Heilongjiang</state>
        <zip>155600</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yingying Sun</last_name>
      <phone>+8613206783965</phone>
      <email>122067727@qq.com</email>
    </contact>
    <investigator>
      <last_name>Yuchen Yuan, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hongxinglong Central Hospital</name>
      <address>
        <city>Shuangyashan</city>
        <state>Heilongjiang</state>
        <zip>155811</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sirui Kang</last_name>
      <phone>+8615146903103</phone>
      <email>248606456@qq.com</email>
    </contact>
    <investigator>
      <last_name>Yuzhu Wang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Suihua First Hospital</name>
      <address>
        <city>Suihua</city>
        <state>Heilongjiang</state>
        <zip>152053</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhan Wang, MD,PhD</last_name>
      <phone>+8613836433343</phone>
      <email>caihengzhihao@163.com</email>
    </contact>
    <investigator>
      <last_name>Hengzhi Cai, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zhan Wang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tieli People's Hospital</name>
      <address>
        <city>Yichun</city>
        <state>Heilongjiang</state>
        <zip>152500</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xin Li</last_name>
      <phone>+8613936266257</phone>
      <email>29334804@qq.com</email>
    </contact>
    <investigator>
      <last_name>Yanbo Niu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yichun First Hospital</name>
      <address>
        <city>Yichun</city>
        <state>Heilongjiang</state>
        <zip>153000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhenyu Yang</last_name>
      <phone>+8613936266257</phone>
      <email>13845858863@139.com</email>
    </contact>
    <investigator>
      <last_name>Daoye Zhang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yichun Forestry Central Hospital</name>
      <address>
        <city>Yichun</city>
        <state>Heilongjiang</state>
        <zip>153000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongyan Diao</last_name>
      <phone>+8613766748268</phone>
      <email>LdJ9900@126.com</email>
    </contact>
    <investigator>
      <last_name>Dajun Li, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaifeng Central Hospital</name>
      <address>
        <city>Kaifeng</city>
        <state>Henan</state>
        <zip>475001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shuai Zhang</last_name>
      <phone>+8613592135892</phone>
      <email>ljy6051@126.com</email>
    </contact>
    <investigator>
      <last_name>Jieyun Liu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Nanyang Medical College</name>
      <address>
        <city>Nanyang</city>
        <state>Henan</state>
        <zip>473007</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Shangqiu</name>
      <address>
        <city>Shangqiu</city>
        <state>Henan</state>
        <zip>476005</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shuai Li</last_name>
      <phone>+8613603700359</phone>
      <email>lishenglisq@163.com</email>
    </contact>
    <investigator>
      <last_name>Shengli Li, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second People's Hospital of Xinxiang City</name>
      <address>
        <city>Xinxiang</city>
        <state>Henan</state>
        <zip>453099</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ning Zhong</last_name>
      <phone>+8618695915951</phone>
      <email>yjx840362@163.com</email>
    </contact>
    <investigator>
      <last_name>Jixia Yan, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yongcheng People's Hospital</name>
      <address>
        <city>Yongcheng</city>
        <state>Henan</state>
        <zip>476600</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhan Chen</last_name>
      <phone>+8615239905101</phone>
      <email>746507077@qq.com</email>
    </contact>
    <investigator>
      <last_name>Changming Tian, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The 7th People's Hospital of Zhengzhou</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450016</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hua Zhang</last_name>
      <phone>+8618236762366</phone>
      <email>476228304@qq.com</email>
    </contact>
    <investigator>
      <last_name>Jing Li, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450052</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yingying Zheng</last_name>
      <phone>+8615214804944</phone>
      <email>jyzhang@zzu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Jinying Zhang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Renmin Hospital of Wuhan University</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Zhongnan Hospital of Wuhan University</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430062</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Yichang First People's Hospital</name>
      <address>
        <city>Yichang</city>
        <state>Hubei</state>
        <zip>443000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huibo Wang</last_name>
      <email>wanghuibo@whu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Jian Yang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410013</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of University of South China</name>
      <address>
        <city>Hengyang</city>
        <state>Hunan</state>
        <zip>421001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jingjing Zhang</last_name>
      <phone>+86 15873438571</phone>
      <email>61052362@qq.com</email>
    </contact>
    <investigator>
      <last_name>Huifang Tang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inner Mongolia People's Hospital</name>
      <address>
        <city>Inner Mongolia</city>
        <state>Inner Mongolia</state>
        <zip>010017</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaopeng Song</last_name>
      <phone>+8615754930692</phone>
      <email>1157714374@qq.com</email>
    </contact>
    <investigator>
      <last_name>Xi Liu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Lianyungang</name>
      <address>
        <city>Lianyungang</city>
        <state>Jiangsu</state>
        <zip>222002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bo Zhao</last_name>
      <phone>+8618961328797</phone>
      <email>zty8888@163.com</email>
    </contact>
    <investigator>
      <last_name>Bo Zhao, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongda Hospital Southeast University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan Huang</last_name>
      <phone>+8615951903992</phone>
      <email>micheliafigo1116@163.com</email>
    </contact>
    <investigator>
      <last_name>Genshan Ma, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pizhou People's Hospital</name>
      <address>
        <city>Pizhou</city>
        <state>Jiangsu</state>
        <zip>221300</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianrong Yin</last_name>
      <phone>+8615380118229</phone>
      <email>yjrpz@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Jianrong Yin, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>First People's Hospital of Fuzhou</name>
      <address>
        <city>Fuzhou</city>
        <state>Jiangxi</state>
        <zip>344000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Third Affiliated Hospital of Jilin University</name>
      <address>
        <city>Chang chun</city>
        <state>Jilin</state>
        <zip>130033</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhongyu Wang</last_name>
      <phone>+8613596478561</phone>
      <email>38236590@qq.com</email>
    </contact>
    <investigator>
      <last_name>Yuquan He, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Jilin University</name>
      <address>
        <city>Chang chun</city>
        <state>Jilin</state>
        <zip>130041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>He Wang</last_name>
      <phone>+8615243120588</phone>
      <email>wanghe221@163.com</email>
    </contact>
    <investigator>
      <last_name>Bin Liu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Changchun Traditional Chinese Medicine University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhaoxi Liu</last_name>
      <phone>+8613578981206</phone>
      <email>lzx620727@126.com</email>
    </contact>
    <investigator>
      <last_name>Qian Tong, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jilin Central Hospital</name>
      <address>
        <city>Jilin</city>
        <state>Jilin</state>
        <zip>132011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fangming Guo</last_name>
      <phone>+8615043283490</phone>
      <email>1409083977@qq.com</email>
    </contact>
    <investigator>
      <last_name>Ying Li, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jilin integrated traditional Chinese and Western Medicine Hospital</name>
      <address>
        <city>Jilin</city>
        <state>Jilin</state>
        <zip>132012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lei Wang</last_name>
      <phone>+8618943207601</phone>
      <email>156191841@qq.com</email>
    </contact>
    <investigator>
      <last_name>Jianping Shi, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital of Jihua Group Company</name>
      <address>
        <city>Jilin</city>
        <state>Jilin</state>
        <zip>132022</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Songyuan Central Hospital</name>
      <address>
        <city>Songyuan</city>
        <state>Jilin</state>
        <zip>138001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianguang Sun</last_name>
      <phone>+8613843800120</phone>
      <email>Sigctshooer@163.com</email>
    </contact>
    <investigator>
      <last_name>Yi Zheng, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Dalian Medical University</name>
      <address>
        <city>Dalian</city>
        <state>Liaoning</state>
        <zip>116011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuxin Yang</last_name>
      <phone>+86 18098871881</phone>
      <email>yangyuxinemc2@126.com</email>
    </contact>
    <investigator>
      <last_name>Bo Zhang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dalian Municipal Cental Hospital</name>
      <address>
        <city>Dalian</city>
        <state>Liaoning</state>
        <zip>116089</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lili Sun</last_name>
      <phone>+8613889659272</phone>
      <email>582632006@qq.com</email>
    </contact>
    <investigator>
      <last_name>Xiaoqun Zheng, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hulunbeir People's Hospital</name>
      <address>
        <city>Hulunbeir</city>
        <state>Neimenggu</state>
        <zip>021008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jingyu Bai</last_name>
      <phone>+8615149223192</phone>
      <email>wugang9700@126.com</email>
    </contact>
    <investigator>
      <last_name>Gang Wu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital of Ningxia Medical University</name>
      <address>
        <city>Yinchuan</city>
        <state>Ningxia</state>
        <zip>750002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Feicheng Hospital of Shandong Guoxin Yiyang Group</name>
      <address>
        <city>Fengcheng</city>
        <state>Shandong</state>
        <zip>271608</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenbo Zhang</last_name>
      <phone>+8615288907118</phone>
      <email>bobowenz@163.com</email>
    </contact>
    <investigator>
      <last_name>Wenbo Zhang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Fifth People's Hospital of Jinan</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250022</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhixin Su</last_name>
      <phone>+8615866618392</phone>
      <email>jiazhisheng126@126.com</email>
    </contact>
    <investigator>
      <last_name>Zhisheng Jia, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Qilu Hospital of Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250063</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhenguo Wu</last_name>
      <phone>+8615098733691</phone>
      <email>yangjianmin@qiluhospital.com</email>
    </contact>
    <investigator>
      <last_name>Jianmin Yang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second People's Hospital of Liaocheng</name>
      <address>
        <city>Liaocheng</city>
        <state>Shandong</state>
        <zip>252699</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yugang Zou</last_name>
      <phone>+8613969554621</phone>
      <email>zyg052311@sina.com</email>
    </contact>
    <investigator>
      <last_name>Yugang Zou, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Taian City Central Hospital</name>
      <address>
        <city>Tai'an</city>
        <state>Shandong</state>
        <zip>271099</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenju Yan</last_name>
      <phone>+8618653876616</phone>
      <email>wishhy@163.com</email>
    </contact>
    <investigator>
      <last_name>Huanyi Zhang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jinlong Li, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wusong hospital Affiliated Zhongshan Hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mengshi Xie</last_name>
      <phone>+8618846071232</phone>
      <email>shi-hy@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Hongyu Shi, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanxi Provincial People's Hospital</name>
      <address>
        <city>Xian</city>
        <state>Shanxi</state>
        <zip>710068</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Xinqiao Hospital Army Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Sichuan</state>
        <zip>400000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Tianjin Medical University General Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300052</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaopeng Xu</last_name>
      <phone>+8613332093191</phone>
      <email>xsplzy@163.com</email>
    </contact>
    <investigator>
      <last_name>Qing Yang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tianjin Chest Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300222</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nan Zhang</last_name>
      <phone>+8613502152283</phone>
      <email>fish7910@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Yin Liu, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chunjie Li, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xinjiang Uiger Municipal People's Hospital</name>
      <address>
        <city>Ürümqi</city>
        <state>Xinjiang</state>
        <zip>830001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhao Wang</last_name>
      <phone>+8613999806773</phone>
      <email>jzzqwz@163.com</email>
    </contact>
    <investigator>
      <last_name>Guoqing Li, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Xinjiang Medical University</name>
      <address>
        <city>Ürümqi</city>
        <state>Xinjiang</state>
        <zip>830054</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qian Zhao</last_name>
      <phone>+8613899993630</phone>
      <email>myt-xj@163.com</email>
    </contact>
    <investigator>
      <last_name>Yitong Ma, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiang Xie, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Chile</country>
    <country>China</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 27, 2020</study_first_submitted>
  <study_first_submitted_qc>November 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 12, 2020</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Harbin Medical University</investigator_affiliation>
    <investigator_full_name>Yu Bo</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>Coronary multivessel disease</keyword>
  <keyword>Dual antiplatelet therapy</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Arteriosclerosis</mesh_term>
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Clopidogrel</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

